Manjusha Gaglani Selected Research

Respiratory Tract Infections (Respiratory Tract Infection)

1/2020	Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness.
1/2018	Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manjusha Gaglani Research Topics

Disease

78	COVID-19 04/2024 - 01/2021
75	Human Influenza (Influenza) 04/2024 - 02/2014
36	Infections 03/2024 - 02/2014
3	Cough 01/2023 - 05/2016
3	Breakthrough Infections 01/2022 - 01/2021
2	Respiratory Insufficiency (Respiratory Failure) 12/2023 - 03/2022
2	Critical Illness (Critically Ill) 05/2023 - 01/2023
2	Fever (Fevers) 10/2022 - 01/2018
2	Disease Progression 10/2022 - 11/2021
2	Pneumonia (Pneumonitis) 01/2022 - 01/2018
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 01/2018
1	Mental Disorders (Mental Disorder) 03/2024
1	Hypoxia (Hypoxemia) 12/2023
1	Renal Insufficiency (Renal Failure) 12/2023
1	Vision Disorders (Hemeralopia) 11/2023
1	Chills 10/2022
1	Hepatitis D 10/2022
1	Coinfection 10/2022
1	Thrombocytopenia (Thrombopenia) 04/2022
1	Thrombosis (Thrombus) 04/2022
1	Asymptomatic Infections 08/2021
1	Drug-Related Side Effects and Adverse Reactions 12/2020
1	Frailty 01/2019
1	Pharyngitis (Sore Throat) 01/2018
1	Sinusitis 01/2018
1	Bronchitis 01/2018
1	Herpesviridae Infections (Herpesvirus Infection) 02/2014
1	Measles 10/2011
1	Mumps 10/2011
1	Chickenpox 10/2011
1	Rubella (German Measles) 10/2011

Drug/Important Bio-Agent (IBA)

103	VaccinesIBA 03/2024 - 10/2011
46	Influenza Vaccines (Influenza Vaccine)FDA Link 02/2024 - 02/2014
38	mRNA VaccinesIBA 02/2024 - 01/2021
36	Messenger RNA (mRNA)IBA 03/2024 - 01/2021
36	COVID-19 VaccinesIBA 03/2024 - 04/2021
11	BNT162 VaccineIBA 01/2023 - 01/2021
10	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2023 - 02/2014
7	N-(2-cyanoethylene)urea (BA 1)IBA 09/2023 - 07/2022
6	Antiviral Agents (Antivirals)IBA 03/2022 - 02/2014
5	Combined VaccinesIBA 01/2024 - 01/2021
5	AntibodiesIBA 12/2023 - 01/2015
5	2019-nCoV Vaccine mRNA-1273IBA 03/2022 - 01/2021
5	Hemagglutinins (Hemagglutinin)IBA 01/2021 - 01/2015
4	Neutralizing AntibodiesIBA 09/2023 - 01/2022
4	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 07/2022
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2022
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 09/2014
2	Oxygen (Dioxygen)IBA 12/2023 - 10/2023
2	Immunoglobulin G (IgG)IBA 11/2023 - 09/2021
2	Viral RNAIBA 11/2023 - 01/2021
2	AntigensIBA 09/2023 - 01/2023
2	Ad26COVS1IBA 10/2022 - 10/2021
2	Attenuated VaccinesIBA 01/2021 - 10/2017
2	Inactivated VaccinesIBA 01/2021 - 12/2018
2	Neuraminidase (Sialidase)IBA 09/2016 - 01/2015
1	Respiratory Syncytial Virus VaccinesIBA 04/2024
1	perfluorooctane sulfonic acidIBA 12/2023
1	perfluorooctanoic acidIBA 12/2023
1	perfluoro-n-nonanoic acidIBA 12/2023
1	perfluorohexanesulfonic acidIBA 12/2023
1	Nucleocapsid ProteinsIBA 11/2023
1	RNA (Ribonucleic Acid)IBA 11/2023
1	EpitopesIBA 09/2023
1	NucleoproteinsIBA 10/2022
1	COVID-19 vaccine booster shotIBA 04/2022
1	Stored Messenger RNAIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 12/2021
1	Nucleic AcidsIBA 11/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	CI 22IBA 01/2019
1	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 10/2011

Therapy/Procedure

21	Ambulatory Care (Outpatient Care) 03/2024 - 09/2014
7	Artificial Respiration (Mechanical Ventilation) 04/2024 - 11/2021
2	Therapeutics 10/2023 - 09/2014
1	Noninvasive Ventilation 10/2023
1	Cannula 10/2023
1	Critical Care (Surgical Intensive Care) 01/2022
1	Mechanical Ventilators (Ventilator) 12/2021
1	Length of Stay 12/2021